Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer

Clinical trial NCT00861471 · TERMINATED

Trial details

NCT number: NCT00861471
Sponsor: NYU Langone Health
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostatic Neoplasms

Start date: 2005-05-01
Primary completion: 2010-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.